SDS

Safety Data Sheet Version: V.1
According to 2012 OSHA Hazard Communication Standard
(29 CFR 1910.1200)
REPORT NO.: KS2002S00167B04
KSIGN(Guangdong) Testing Co., Ltd. Page 8 of 12
Component Information
Chemical Name
Oral LD50
Dermal LD50
Inhalation LC50
Carbon black
1333-86-4
> 10000 mg/kg ( Rat )
> 3 g/kg ( Rabbit )
-
Information on toxicological effects
Symptoms
Erythema (skin redness). May cause redness and tearing of the eyes.
Itching. Rashes. Hives.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization:
May cause sensitization of susceptible persons. May cause sensitization by
skin contact.
Mutagenic Effects:
No information available.
Carcinogenicity:
The table below indicates whether each agency has listed any ingredient as
a carcinogen.
Chemical Name
ACGIH
IARC
NTP
OSHA
Lithium Cobalt Oxide
(CoLiO
2
)
12190-79-3
A3
Group 2B
X
Carbon black
1333-86-4
A3
Group 2B
X
ACGIH (American Conference of Governmental Industrial Hygienists)
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 2B - Possibly Carcinogenic to Humans
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive Toxicity
No information available.
STOT - single exposure
No information available.
STOT - repeated exposure
Causes damage to organs through prolonged or repeated exposure. Based
on classification criteria from the 2012 OSHA Hazard Communication
Standard (29 CFR 1910.1200), this product has been determined to cause
systemic target organ toxicity from chronic or repeated exposure. (STOT
RE).
Chronic Toxicity
Contains a known or suspected carcinogen. Avoid repeated exposure.
Prolonged exposure may cause chronic effects. May cause adverse liver
effects.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Central Vascular
System (CVS).Kidney. Liver. Liver. Cardiovascular system. Systemic
Toxicity.
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on
chapter 3.1 of the GHS document
ATEmix (oral):
12,905.00 mg/kg
ATEmix (dermal):
10,200.00 mg/kg (ATE)